Clinical trial
COMT Polymorphism and Entacapone Efficacy
NCT00373087 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00373087 |
|---|---|
| Title | COMT Polymorphism and Entacapone Efficacy |
| Official title | Influence of Catechol-O-methyltransferase Polymorphism on Entacapone Efficacy in Parkinson's Disease |
| Acronym | COMT |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | entacapone, l dopa versus placebo |
| Enrollment | 60 |
| Start date | Oct 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Sep 7, 2006 |
| Last update posted | Apr 29, 2010 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: